• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk factors for incomplete excision of cutaneous squamous cell carcinoma: a large cohort study.皮肤鳞状细胞癌切除不完全的风险因素:一项大型队列研究。
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):1229-1234. doi: 10.1111/jdv.18101. Epub 2022 Apr 20.
2
Predictors of Recurrence and Progression in Poorly Differentiated Cutaneous Squamous Cell Carcinomas: Insights from a Real-Life Experience.低分化皮肤鳞状细胞癌复发和进展的预测因素:真实经验的启示。
Dermatology. 2024;240(2):329-336. doi: 10.1159/000535040. Epub 2023 Nov 26.
3
Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis.广泛神经周围侵犯与神经纤维直径比评估皮肤鳞状细胞癌预后。
JAMA Dermatol. 2023 Dec 1;159(12):1332-1338. doi: 10.1001/jamadermatol.2023.3703.
4
Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis.皮肤鳞状细胞癌复发、转移及疾病特异性死亡的危险因素:一项系统评价和Meta分析
JAMA Dermatol. 2016 Apr;152(4):419-28. doi: 10.1001/jamadermatol.2015.4994.
5
The prognostic significance of lymphovascular invasion in cutaneous squamous cell carcinoma.淋巴管浸润在皮肤鳞状细胞癌中的预后意义。
ANZ J Surg. 2023 Nov;93(11):2727-2735. doi: 10.1111/ans.18694. Epub 2023 Sep 19.
6
Implications of Satellitosis or In-transit Metastasis in Cutaneous Squamous Cell Carcinoma: A Prognostic Omission in Cancer Staging Systems.卫星灶或转移灶在皮肤鳞状细胞癌中的意义:癌症分期系统中的预后遗漏。
JAMA Dermatol. 2022 Apr 1;158(4):390-394. doi: 10.1001/jamadermatol.2022.0001.
7
Tracking the risk factors associated with high-risk cSCC: A 10-year, Two-Institution, Greek study.追踪与高危 cSCC 相关的风险因素:一项为期 10 年、涉及 2 家机构的希腊研究。
J BUON. 2021 May-Jun;26(3):1148-1158.
8
Beyond the dermis-high-risk invasive squamous cell carcinoma: a retrospective review.真皮层以上高危侵袭性鳞状细胞癌:回顾性研究。
J Wound Care. 2020 Oct 2;29(10):556-561. doi: 10.12968/jowc.2020.29.10.556.
9
Oncologic outcomes in primary squamous cell carcinoma of the auricle: a retrospective cohort analysis.耳廓原发性鳞状细胞癌的肿瘤学结局:回顾性队列分析。
Eur Arch Otorhinolaryngol. 2022 Jan;279(1):335-341. doi: 10.1007/s00405-021-06763-z. Epub 2021 May 6.
10
Factors Associated with Recurrence and Regional Adenopathy for Head and Neck Cutaneous Squamous Cell Carcinoma.头颈部皮肤鳞状细胞癌复发及区域淋巴结肿大的相关因素
Otolaryngol Head Neck Surg. 2017 May;156(5):863-869. doi: 10.1177/0194599817697053. Epub 2017 Mar 21.

引用本文的文献

1
Letter to the editor regarding "Risk factors for incomplete excision of cutaneous squamous cell carcinoma: A single-center study performed on 1082 excisions in Northern Italy".致编辑的信:关于“皮肤鳞状细胞癌切除不完全的危险因素:在意大利北部对1082例切除术进行的单中心研究”
JPRAS Open. 2025 Aug 7;45:471-472. doi: 10.1016/j.jpra.2025.08.010. eCollection 2025 Sep.
2
PD-L1 Inhibitor Cosibelimab for Cutaneous Squamous Cell Carcinoma: Comprehensive Evaluation of Efficacy, Mechanism, and Clinical Trial Insights.用于皮肤鳞状细胞癌的程序性死亡受体配体1(PD-L1)抑制剂科斯贝利单抗:疗效、机制及临床试验见解的综合评估
Biomedicines. 2025 Apr 7;13(4):889. doi: 10.3390/biomedicines13040889.
3
Risk factors for incomplete excision of cutaneous squamous cell carcinoma: A single-center study performed on 1082 excisions in Northern Italy.皮肤鳞状细胞癌切除不完全的危险因素:在意大利北部对1082例切除术进行的单中心研究。
JPRAS Open. 2025 Mar 6;44:316-330. doi: 10.1016/j.jpra.2025.02.007. eCollection 2025 Jun.
4
Cutaneous Squamous Cell Carcinoma of the Head and Neck: Pathological Features and What They Mean for Prognosis and Treatment.头颈部皮肤鳞状细胞癌:病理特征及其对预后和治疗的意义
Cancers (Basel). 2024 Aug 17;16(16):2866. doi: 10.3390/cancers16162866.
5
Histological deep margins in cutaneous squamous cell carcinoma of the scalp and risk of recurrence.头皮皮肤鳞状细胞癌的组织学深部切缘与复发风险
J Eur Acad Dermatol Venereol. 2025 Apr;39(4):855-864. doi: 10.1111/jdv.20250. Epub 2024 Jul 22.
6
Molecular and Histopathological Characterization of Metastatic Cutaneous Squamous Cell Carcinomas: A Case-Control Study.转移性皮肤鳞状细胞癌的分子和组织病理学特征:一项病例对照研究。
Cancers (Basel). 2024 Jun 15;16(12):2233. doi: 10.3390/cancers16122233.
7
Increased CD56 expression after photodynamic therapy indicates an increased natural killer cell count following early photodynamic therapy for cutaneous squamous cell carcinoma.光动力治疗后CD56表达增加表明皮肤鳞状细胞癌早期光动力治疗后自然杀伤细胞计数增加。
Oncol Lett. 2024 Jun 13;28(2):372. doi: 10.3892/ol.2024.14505. eCollection 2024 Aug.
8
Recent Changes in the Incidence and Characteristics of Cutaneous Squamous Cell Carcinomas in Finland from 2006 to 2020: A Retrospective Cohort Study.2006 至 2020 年芬兰皮肤鳞状细胞癌发病率和特征的近期变化:一项回顾性队列研究。
Acta Derm Venereol. 2024 May 30;104:adv39891. doi: 10.2340/actadv.v104.39891.

本文引用的文献

1
Update of advanced cutaneous squamous cell carcinoma.晚期皮肤鳞状细胞癌的更新。
J Eur Acad Dermatol Venereol. 2022 Jan;36 Suppl 1(Suppl 1):6-10. doi: 10.1111/jdv.17728.
2
Local Recurrence Rates of Skin Tumors After Resection With Complete Circumferential Peripheral and Deep Margin Assessment-Identification of High-Risk Entities.完整的环周外周和深层切缘评估后切除皮肤肿瘤的局部复发率——高危实体的识别。
Dermatol Surg. 2021 Feb 1;47(2):e31-e36. doi: 10.1097/DSS.0000000000002431.
3
Incomplete Excision of Cutaneous Squamous Cell Carcinoma; Systematic Review of the Literature.皮肤鳞状细胞癌不完全切除;文献系统评价。
Acta Derm Venereol. 2020 Mar 18;100(6):adv00084. doi: 10.2340/00015555-3441.
4
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.欧洲多学科指南:侵袭性鳞状细胞皮肤癌 第 2 部分:治疗。
Eur J Cancer. 2020 Mar;128:83-102. doi: 10.1016/j.ejca.2020.01.008. Epub 2020 Feb 26.
5
Metastasis of cutaneous squamous cell carcinoma in organ transplant recipients and the immunocompetent population: is there a difference? a systematic review and meta-analysis.器官移植受者和免疫功能正常人群中皮肤鳞状细胞癌转移:有区别吗?系统评价和荟萃分析。
J Eur Acad Dermatol Venereol. 2019 May;33(5):828-841. doi: 10.1111/jdv.15396. Epub 2019 Feb 22.
6
Update on Keratinocyte Carcinomas.皮肤角质形成细胞癌的最新进展
N Engl J Med. 2018 Jul 26;379(4):363-374. doi: 10.1056/NEJMra1708701.
7
Risk factors for positive margins after wide local excision of cutaneous squamous cell carcinoma.皮肤鳞状细胞癌广泛局部切除术后切缘阳性的危险因素。
J Dermatolog Treat. 2018 Nov;29(7):706-708. doi: 10.1080/09546634.2018.1441493. Epub 2018 Feb 25.
8
Guidelines of care for the management of cutaneous squamous cell carcinoma.皮肤鳞状细胞癌治疗指南。
J Am Acad Dermatol. 2018 Mar;78(3):560-578. doi: 10.1016/j.jaad.2017.10.007. Epub 2018 Jan 10.
9
Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis.皮肤鳞状细胞癌复发、转移及疾病特异性死亡的危险因素:一项系统评价和Meta分析
JAMA Dermatol. 2016 Apr;152(4):419-28. doi: 10.1001/jamadermatol.2015.4994.
10
Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.皮肤浸润性鳞状细胞癌的诊断与治疗:基于欧洲共识的跨学科指南
Eur J Cancer. 2015 Sep;51(14):1989-2007. doi: 10.1016/j.ejca.2015.06.110. Epub 2015 Jul 25.

皮肤鳞状细胞癌切除不完全的风险因素:一项大型队列研究。

Risk factors for incomplete excision of cutaneous squamous cell carcinoma: a large cohort study.

机构信息

Department of Dermatology, Leiden University Medical Centre, Leiden, The Netherlands.

Department of Dermatology, Ziekenhuisgroep Twente, Hengelo, The Netherlands.

出版信息

J Eur Acad Dermatol Venereol. 2022 Aug;36(8):1229-1234. doi: 10.1111/jdv.18101. Epub 2022 Apr 20.

DOI:10.1111/jdv.18101
PMID:35342992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9545629/
Abstract

BACKGROUND

The standard treatment for cutaneous squamous cell carcinoma (cSCC) is surgical excision. Failure to radically remove a cSCC is a risk for recurrence, progression and metastasis.

OBJECTIVES

This study investigates several risk factors for incomplete excision of cSCC.

METHODS

All consecutive patients in a single institution treated with wide local excision for primary cSCC over a 10-year period were included in this study. Risk factors such as: gender, age, immunosuppression, tumour size, location, differentiation grade, tumour depth, perineural and lymphovascular invasion (PNI and LVI) were extracted from the database. Univariable and (if applicable) multivariable logistic regression analysis were used to identify risk factors (P < 0.05). Generalized estimating equations (GEEs) were used for multiple tumours within the same patients.

RESULTS

A total of 566 patients with 1159 cSCC were identified. Univariable and multivariable logistic regression analysis showed that depth beyond the dermis (OR: 5.7 95% CI: 3.1-10.5) was the only risk factor for incomplete excision of cSCC. Immunosuppression was only a risk factor in the deep plane (OR: 2.5, 95% CI: 1.3-4.6).

CONCLUSION

Tumour depth beyond the dermis is the most important risk factor for incomplete excision of cSCC. Immunosuppression is a risk factor in the deep plane but its relevance is uncertain. Immunosuppression is not consistently included in the current cSCC staging systems, but care should be taken when treating these patients.

摘要

背景

皮肤鳞状细胞癌(cSCC)的标准治疗方法是手术切除。未能彻底切除 cSCC 会增加复发、进展和转移的风险。

目的

本研究探讨了导致 cSCC 切除不完全的若干危险因素。

方法

本研究纳入了在单家机构接受广泛局部切除术治疗的 10 年内连续的原发性 cSCC 患者。从数据库中提取了性别、年龄、免疫抑制、肿瘤大小、位置、分化程度、肿瘤深度、神经周围和脉管侵犯(PNI 和 LVI)等危险因素。采用单变量和(如有必要)多变量逻辑回归分析来识别危险因素(P<0.05)。对于同一患者中的多个肿瘤,使用广义估计方程(GEE)。

结果

共纳入 566 例患者的 1159 例 cSCC。单变量和多变量逻辑回归分析表明,真皮深层浸润(OR:5.7,95%CI:3.1-10.5)是 cSCC 切除不完全的唯一危险因素。免疫抑制仅在深层平面是危险因素(OR:2.5,95%CI:1.3-4.6)。

结论

真皮深层浸润是导致 cSCC 切除不完全的最重要危险因素。免疫抑制是深层平面的危险因素,但相关性不确定。免疫抑制目前并未被纳入 cSCC 的分期系统,但在治疗这些患者时应谨慎。